[{"NetIncomeLoss_2_Q2_USD":-125866000.0,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_Q2_USD":61146000.0,"InterestPaidNet_2_Q2_USD":3419000.0,"InventoryFinishedGoods_0_Q2_USD":1507000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":1227000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q2_USD":2395000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":199884000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_2_Q2_USD":52.93,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":666633.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":12564000.0,"AssetsCurrent_0_Q2_USD":594033000.0,"LongTermDebt_0_Q2_USD":104343000.0,"NoninterestExpense_2_Q2_USD":4596000.0,"NoninterestExpense_1_Q2_USD":2282000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":96736000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":49075000.0,"DebtInstrumentUnamortizedDiscount_0_Q2_USD":600000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":512000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":51580000.0,"ShareBasedCompensation_2_Q2_USD":32938000.0,"Assets_0_Q2_USD":721667000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":574009000.0,"LossContingencyAccrualProvision_2_Q2_USD":0.0,"CommonStockSharesIssued_0_Q2_shares":61330987.0,"AccruedLiabilitiesCurrent_0_Q2_USD":43733000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":12202000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":8018000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":6441334.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":6441334.0,"NoninterestIncome_1_Q2_USD":1514000.0,"NoninterestIncome_2_Q2_USD":4370000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":377000.0,"LossContingencyLossInPeriod_2_Q2_USD":0.0,"CommitmentsAndContingencies_0_Q2_USD":null,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":61116707.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":60952269.0,"AvailableForSaleSecuritiesCurrent_0_Q2_USD":156014000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":8698000.0,"IncreaseDecreaseInEmployeeRelatedLiabilities_2_Q2_USD":-1114000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_2_Q2_shares":297650.0,"DepreciationDepletionAndAmortization_2_Q2_USD":5577000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q2_USD":13347000.0,"CostsAndExpenses_2_Q2_USD":171106000.0,"CommonStockValue_0_Q2_USD":61000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-379000.0,"InventoryRawMaterials_0_Q2_USD":10210000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":128845000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":41.61,"ResearchAndDevelopmentExpense_1_Q2_USD":34085000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":73858000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-804000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.001,"CostsAndExpenses_1_Q2_USD":83537000.0,"AvailableForSaleSecuritiesGrossUnrealizedLoss_2_Q2_USD":2000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"AvailableForSaleSecuritiesAmortizedCost_0_Q2_USD":572782000.0,"OperatingLeaseLiability_0_Q2_USD":85389000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":12000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":472000.0,"IncreaseDecreaseInOtherAccruedLiabilities_2_Q2_USD":-1326000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_2_Q2_USD":261738000.0,"Liabilities_0_Q2_USD":225851000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":384716000.0,"OtherAssetsNoncurrent_0_Q2_USD":512000.0,"OperatingLeasesIncomeStatementDepreciationExpenseOnPropertySubjectToOrHeldForLease_2_Q2_USD":3800000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-52828000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-125394000.0,"IncreaseDecreaseInInventories_2_Q2_USD":24926000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":81903000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":4837000.0,"IncreaseDecreaseInOtherCurrentLiabilities_2_Q2_USD":156000.0,"AvailableForSaleSecuritiesGrossUnrealizedGains_2_Q2_USD":1229000.0,"VariableLeaseCost_2_Q2_USD":1300000.0,"VariableLeaseCost_1_Q2_USD":600000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-864782000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":9834000.0,"CommonStockSharesOutstanding_0_Q2_shares":61330987.0,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":57936000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":7290000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2_Q2_USD":2172000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":17128000.0,"MarketableSecuritiesUnrealizedGainLoss_1_Q2_USD":12000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-126103000.0,"InventoryWorkInProcess_0_Q2_USD":15617000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":11822000.0,"LiabilitiesCurrent_0_Q2_USD":69402000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_Q2_USD":82479000.0,"AccountsPayableCurrent_0_Q2_USD":5690000.0,"PaymentsOfDebtIssuanceCosts_2_Q2_USD":130000.0,"NetIncomeLoss_1_Q2_USD":-52840000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":39668000.0,"ReceivablesNetCurrent_0_Q2_USD":12471000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":368391.0,"OperatingLeasePaymentsUse_2_Q2_USD":2590000.0,"TaxesPayableCurrent_0_Q2_USD":30000.0,"CashEquivalentsAtCarryingValue_0_Q2_USD":384516000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.087,"InterestExpenseDebt_2_Q2_USD":27843000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":4415000.0,"LongTermDebtNoncurrent_0_Q2_USD":73775000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":13498000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":387111000.0,"AdditionalPaidInCapital_0_Q2_USD":1359310000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":3574452.0,"AmortizationOfFinancingCostsAndDiscounts_2_Q2_USD":824000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q2_USD":31501000.0,"OperatingLeaseCost_1_Q2_USD":3100000.0,"OperatingLeaseCost_2_Q2_USD":6200000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":24.39,"PreferredStockValue_0_Q2_USD":null,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":65.91,"AvailableForSaleSecuritiesNoncurrent_0_Q2_USD":33479000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":721667000.0,"InventoryNet_0_Q2_USD":27334000.0,"OperatingIncomeLoss_2_Q2_USD":-125487000.0,"CommonStockSharesAuthorized_0_Q2_shares":150000000.0,"IncreaseDecreaseInAccountsPayableTrade_2_Q2_USD":-4918000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":-181000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":12927000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":43456000.0,"OperatingIncomeLoss_1_Q2_USD":-52036000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":16463000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":32938000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_2_Q2_USD":45619000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":61000.0,"DebtInstrumentCarryingAmount_0_Q2_USD":75000000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":3918000.0,"StockholdersEquity_0_Q2_USD":495816000.0,"OtherLiabilitiesCurrent_0_Q2_USD":3516000.0,"PreferredStockSharesAuthorized_0_Q2_shares":5000000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":771000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-2.06,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2_Q2_USD":205000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":3486000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":46958000.0,"StockIssuedDuringPeriodValueRestrictedStockAwardGross_1_Q2_USD":-74000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":16571000.0,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.86,"AccruedProfessionalFeesCurrent_0_Q2_USD":3283000.0,"Ticker":"GBT","CIK":"1629137","name":"GLOBAL BLOOD THERAPEUTICS, INC.","OfficialName":"Global Blood Therapeutics Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"2","uom":"USD","footnote":"nan","Market Cap":"2248655788.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200805"}]